{"id":{"repo_id":"tdl","oai_identifier":"oai:tdl-ir.tdl.org:20.500.12503/32460"},"canonical_url":"https://search.dev.ndltd.org/etd/tdl/oai:tdl-ir.tdl.org:20.500.12503/32460","repository":{"repo_id":"tdl","name":"Texas Digital Library","base_url":"https://tdl-ir.tdl.org/server/oai/request"},"display":{"title":"Diversified use of Non-invasive Biomarkers in Study Protocol and Screen failure in Non-Alcoholic Steatohepatitis (NASH)","abstract":"This study examines how non-invasive biomarkers of NASH are introduced into the study protocol and whether this has an impact on screen failure. The study will investigate the use of non-invasive biomarkers in the design of study protocols for NASH drug trials and will also examine if screening approaches established using non-invasive biomarkers can reduce screen failure.","abstract_html":"This study examines how non-invasive biomarkers of NASH are introduced into the study protocol and whether this has an impact on screen failure. The study will investigate the use of non-invasive biomarkers in the design of study protocols for NASH drug trials and will also examine if screening approaches established using non-invasive biomarkers can reduce screen failure.","abstract_has_math":false,"creators":["Masaye, Nikita P."],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Gregory, Paula"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023-05","date_published":"2023-05","updated_at":"2026-07-27T21:19:06Z","subjects":["NASH"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/20.500.12503/32460","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Gregory, Paula"]},{"key":"dc:creator","label":"Author","values":["Masaye, Nikita P."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2024-01-23T21:28:15Z","2026-03-24T17:21:32Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2024-01-23T21:28:15Z"]},{"key":"dc:date.issued","label":"Date","values":["2023-05"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["NASH"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://hdl.handle.net/20.500.12503/32460"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/20.500.12503/32460"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["This study examines how non-invasive biomarkers of NASH are introduced into the study protocol and whether this has an impact on screen failure. The study will investigate the use of non-invasive biomarkers in the design of study protocols for NASH drug trials and will also examine if screening approaches established using non-invasive biomarkers can reduce screen failure."]},{"key":"dc:title","label":"Title","values":["Diversified use of Non-invasive Biomarkers in Study Protocol and Screen failure in Non-Alcoholic Steatohepatitis (NASH)"]}]}],"canonical_facts":{"dc:contributor":["Gregory, Paula"],"dc:creator":["Masaye, Nikita P."],"dc:date.accessioned":["2024-01-23T21:28:15Z","2026-03-24T17:21:32Z"],"dc:date.available":["2024-01-23T21:28:15Z"],"dc:date.issued":["2023-05"],"dc:description.abstract":["This study examines how non-invasive biomarkers of NASH are introduced into the study protocol and whether this has an impact on screen failure. The study will investigate the use of non-invasive biomarkers in the design of study protocols for NASH drug trials and will also examine if screening approaches established using non-invasive biomarkers can reduce screen failure."],"dc:identifier":["https://hdl.handle.net/20.500.12503/32460"],"dc:identifier.uri":["https://hdl.handle.net/20.500.12503/32460"],"dc:language":["en"],"dc:subject":["NASH"],"dc:title":["Diversified use of Non-invasive Biomarkers in Study Protocol and Screen failure in Non-Alcoholic Steatohepatitis (NASH)"],"dc:type":["Thesis"]},"updated_at":"2026-07-27T21:19:06Z"}